Perrigo (NYSE:PRGO) received a $107.00 price objective from stock analysts at Cantor Fitzgerald in a research note issued on Saturday, December 16th. The firm presently has a “buy” rating on the stock. Cantor Fitzgerald’s target price indicates a potential upside of 16.32% from the company’s current price.
A number of other brokerages also recently issued reports on PRGO. Barclays upped their price target on Perrigo to $93.00 and gave the stock an “overweight” rating in a research report on Monday, December 4th. Royal Bank of Canada reaffirmed a “sell” rating and set a $64.00 price target on shares of Perrigo in a research report on Wednesday, September 13th. Deutsche Bank upped their price target on Perrigo from $88.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday, September 14th. Oppenheimer started coverage on Perrigo in a research report on Monday, October 2nd. They set a “buy” rating and a $88.00 price target on the stock. Finally, Wells Fargo & Co upped their price target on Perrigo to $90.00 and gave the stock a “market perform” rating in a research report on Friday, November 10th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $92.00.
Shares of Perrigo (PRGO) traded up $1.91 during trading hours on Friday, reaching $91.99. 981,054 shares of the company were exchanged, compared to its average volume of 1,063,094. The company has a market capitalization of $12,790.00, a P/E ratio of -10.04, a price-to-earnings-growth ratio of 1.92 and a beta of 0.64. Perrigo has a 52 week low of $63.68 and a 52 week high of $92.16. The company has a quick ratio of 1.24, a current ratio of 1.72 and a debt-to-equity ratio of 0.54.
Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Thursday, November 9th. The company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.28. The company had revenue of $1.22 billion during the quarter, compared to the consensus estimate of $1.17 billion. Perrigo had a negative net margin of 26.28% and a positive return on equity of 11.60%. Perrigo’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.65 earnings per share. equities analysts anticipate that Perrigo will post 4.88 earnings per share for the current fiscal year.
In related news, VP Todd W. Kingma sold 1,500 shares of the firm’s stock in a transaction dated Friday, December 28th. The shares were sold at an average price of $88.52, for a total value of $132,780.00. Following the transaction, the vice president now directly owns 19,565 shares of the company’s stock, valued at approximately $1,731,893.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP John Wesolowski sold 450 shares of the firm’s stock in a transaction dated Thursday, December 7th. The shares were sold at an average price of $83.09, for a total transaction of $37,390.50. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,051 shares of company stock worth $355,370. Corporate insiders own 6.90% of the company’s stock.
A number of institutional investors have recently modified their holdings of the stock. Parametric Portfolio Associates LLC lifted its stake in Perrigo by 29.6% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 229,115 shares of the company’s stock valued at $19,395,000 after buying an additional 52,361 shares in the last quarter. Greenlight Capital Inc. raised its holdings in Perrigo by 14.8% in the 3rd quarter. Greenlight Capital Inc. now owns 2,901,032 shares of the company’s stock valued at $245,572,000 after acquiring an additional 374,032 shares during the last quarter. Cetera Advisors LLC acquired a new stake in Perrigo in the 3rd quarter valued at about $398,000. California Public Employees Retirement System raised its holdings in Perrigo by 3.9% in the 3rd quarter. California Public Employees Retirement System now owns 284,066 shares of the company’s stock valued at $24,046,000 after acquiring an additional 10,766 shares during the last quarter. Finally, Point72 Asset Management L.P. acquired a new stake in Perrigo in the 3rd quarter valued at about $12,706,000. 83.29% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: This news story was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/01/11/perrigo-prgo-given-a-107-00-price-target-at-cantor-fitzgerald-2.html.
Perrigo Company Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.